The Josep Carreras Leukaemia Research Institute (IJC) is a comprehensive cancer research center dedicated to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of leukaemia and other hematologic malignancies, with the final aim of finding a cure for these diseases. It was created in 2010, and since then has experienced an exponential growth.
The IJC is also part of the network of Excellence Research Centers of Catalonia (CERCA) and was accredited as a Severo Ochoa Center of Excellence by the Ministry of Science, Innovation, and Universities in 2024. Since 2018, the Institute has also been accredited by the Scientific Foundation of the Spanish Association Against Cancer (FCAECC) Additionally, IJC is one of the centers integrated into the Institut de Recerca Germans Trias i Pujol (IGTP) accreditation as Accredited Health Research Institute (IIS) by the Carlos III Health Institute (ISCIII).
The IJC's main headquarters is located within the Can Ruti Biomedical Campus, alongside other leading biomedical institutions, providing direct access to cutting-edge scientific and technological facilities, as well as complementary community services. The IJC has six locations integrated into reference hospitals: Hospital Germans Trias i Pujol, Hospital Clínic, Hospital Sant Pau, Hospital Josep Trueta, Hospital del Mar and Hospital San Joan de Déu. This facilitates close collaboration between basic and clinical researchers, fostering translational research that integrates basic science with clinical practice in clinical settings.
The Josep Carreras Leukemia Research Institute is looking for a Laboratory Technician in the Stem cell biology, developmental leukemia and immunotherapy group led by Dr. Pablo Menéndez.
RESEARCH DESCRIPTION
The Stem Cell Biology, Developmental Leukemia and Immunotherapy Group, led by Dr. Pablo Menendez, is interested in understanding the cellular origin, etiology and pathogenesis of childhood leukemia. We aim to ascertain the cell in which mutations occur and we strive to discover which cells are responsible for triggering relapses. Furthermore, we work to identify new therapeutic targets and develop more targeted, less toxic therapies. To achieve this, our laboratory uses various approaches, including genetic studies, epigenetic techniques and animal models, as well as adoptive cell immunotherapy tools.
MAIN RESPONSABILITIES
- Support in the management and handling of the laboratory’s different mouse colonies.
- Support in in vivo experiments, including administration of substances through different routes, IVIS imaging, euthanasia, and sample collection and processing.
- Support in monitoring animal welfare.
- Support in the general management and organization of the laboratory.
- Support in tissue sample processing.
- Support in molecular and cell biology techniques.
WHAT WE NEED
- Degree or technical qualification in Biology, Human Nutrition, Pharmacy, Biotechnology or a related field.
- Accredited Training Course for Laboratory Animal Personnel (Functions a–c: Care and Euthanasia) in rodents.
- Experience with mouse models, especially in the context of handling of laboratory animals, colony management, and animal welfare monitoring.
- Experience in substance administration through different routes will be considered an asset, including intraperitoneal, intravenous, subcutaneous, intratibial, intrahepatic, and oral gavage administration.
- Fluency in English will be considered a plus.
- Willingness to learn and strong teamwork skills
- Pro-active, responsible and well-organized
- Good interpersonal skills and ability to work with other team members
WHAT WE OFFER
- Permanent contract (Contrato indefinido por actividades científico-técnicas (IACT)) La contratación es parte del proyecto “Inestabilidad cromosómica y patofisiología de las células iniciadoras de leucemia en la leucemia linfoblástica aguda pediátrica con aneuploidías.” referencia PID2022-142966OB-I00 financiado por MCIN/AEI/10.13039/501100011033 y por FEDER, Una manera de hacer Europa.
- Full-time contract (39 working hours per week).
- An exciting and innovative research project.”
- Measures to reconcile work and family life.
- Flexible remuneration program (kindergarten and other measures).
- The opportunity to contribute to cutting-edge research projects in molecular biology and translational research.
- Work in a mixed basic and clinical research environment at the Josep Carreras Leukaemia Research Institute.
- The stimulating environment of the IJC and its scientific network.
DEADLINE
Please submit your application by July 22nd, 2026.
WHO WE ARE?
The mission of the Josep Carreras Leukaemia Research Institute is to conduct research and drive innovation in the epidemiological, preventive, clinical, translational, and basic aspects of cancer, with a special emphasis on Leukaemia and other malignant blood diseases, with the aim of finding a cure for these diseases.
The IJC’s vision is to be a world-class reference and excellent research center that contributes to the improvement of results, and the cure of patients affected by leukaemia and other malignant haemopathies, through innovation, sustainability, social responsibility, talent, and professional experience.
In 2019, IJC was honored with the “Human Resources Excellence in Research Award” by the European Commission, recognizing the alignment of our human resources policies with the European Charter for Researchers and Code of Conduct for the Recruitment of Researchers. The Human Resources Strategy for Researchers (HRS4R) guides research centers of excellence in implementing and upholding these standards within their policies, emphasizing training, professional development, and mobility opportunities.
The IJC’s commitment to these values and principles strengthens our internal policies and ensures that our members have the optimal conditions and environment for their professional development.
The Board of Trustees is composed of representatives of the Generalitat de Catalunya (regional government), University of Barcelona, Autonomous University of Barcelona, the City of Badalona and the Jose Carreras International Leukaemia Foundation
The Catalan government provides hard money on an annual basis. The Jose Carreras International Leukaemia Foundation provides start-up funds, project funds as well as financial support for investments.
The JCI has an international scientific advisory board served by prominent researchers from US and Europe.
The IJC has been awarded ERC and other EU grants.
The IJC is an equal-opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, or other legally protected characteristics.
